US Amlodipine Besylate Prices Jump 10% in April 2026 Amidst Global Geopolitical Uncertainties

US Amlodipine Besylate Prices Jump 10% in April 2026 Amidst Global Geopolitical Uncertainties

Lewis Carroll 14-May-2026

April activity in US Amlodipine Besylate markets advanced as regulatory bottlenecks, logistics frictions and purchasing behavior tightened spot availability, supporting firmer offers. Distributors rebuilt safety stocks after Q1 destocking tied to negotiating dynamics, and hospital groups advanced portions of Q2 tenders into April, lifting spot inquiries. Stricter Trans-Pacific container rates and longer Los Angeles port dwell times further compressed landed supply, underpinning firmer seller pricing. Demand from cardiovascular generics and finished-dosage manufacturers remained the core support. Prescription audit data showed steady month-to-month filled prescriptions, maintaining baseline consumption, while distributors and tenders boosted short-term pull-through for APIs used in amlodipine products. The spot price rose about ten percent, underscoring tightness. Outlook remains constructive in the near term but hinges on Asian throughput, freight costs, and regulatory costs abating, with upside momentum through May–July before a plateau.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.